Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Oligodendroglioma 1Medulloblastoma 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

Specimen Handling 118Magnetic Resonance Spectroscopy 115Cyclophosphamide 98pembrolizumab 82Radiotherapy 78Nivolumab 67Cisplatin 64fludarabine 59Biopsy 55Carboplatin 53Standard of Care 45Radiosurgery 43Dexamethasone 40Gemcitabine 39Radiation 37Paclitaxel 36venetoclax 35Rituximab 35Cytarabine 35Bevacizumab 35Surveys and Questionnaires 34Doxorubicin 33fludarabine phosphate 31Temozolomide 31Radiotherapy, Intensity-Modulated 30Capecitabine 30Practice Guidelines as Topic 29Blood Specimen Collection 29Interviews as Topic 28Fluorouracil 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diphtheria-Tetanus Vaccine × 30 days × Clear all
NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting
12 enrolled
CNS

Brain Neoplasms, Oligodendroglioma

NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡